CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-22 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,184 | $8.71 | $10K | 305,500 |
| 2024-05-06 | Joshi Mehul Chief Financial Officer & PAO | Grant or award | +125,870 | 125,870 | ||
| 2024-05-06 | Joshi Mehul Chief Financial Officer & PAO | Grant or award · Employee Stock Option (right to buy) | +241,409 | 241,409 | ||
| 2024-04-22 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,184 | $7.49 | $9K | 306,684 |
| 2024-03-22 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,184 | $9.36 | $11K | 307,868 |
| 2024-03-15 | Williamson Steven S. PRESIDENT AND CEO | Grant or award | +205,286 | 205,286 | ||
| 2024-03-15 | Williamson Steven S. PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +425,116 | 425,116 | ||
| 2024-03-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Grant or award | +69,100 | 309,052 | ||
| 2024-03-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +34,500 | 34,500 | ||
| 2024-03-01 | McKune John INTERIM CFO | Grant or award | +28,800 | 76,210 | ||
| 2024-03-01 | McKune John INTERIM CFO | Grant or award · Employee Stock Option (right to buy) | +14,400 | 14,400 | ||
| 2024-03-01 | Lehman David Aaron GENERAL COUNSEL | Grant or award | +69,100 | 214,588 | ||
| 2024-03-01 | Lehman David Aaron GENERAL COUNSEL | Grant or award · Employee Stock Option (right to buy) | +34,500 | 34,500 | ||
| 2024-03-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −428 | $9.06 | $4K | 242,621 |
| 2024-03-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −753 | $9.06 | $7K | 241,868 |
| 2024-03-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,916 | $9.06 | $17K | 239,952 |
| 2024-03-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Grant or award | +34,500 | 274,452 | ||
| 2024-03-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +69,100 | 69,100 | ||
| 2024-03-01 | McKune John INTERIM CFO | Sale | −155 | $9.06 | $1K | 48,333 |
| 2024-03-01 | McKune John INTERIM CFO | Sale | −254 | $9.06 | $2K | 48,079 |
Page 9 of 12 · 235 trades